Int Neurourol J.  2016 May;20(Suppl 1):S30-S37.

Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer

Affiliations
  • 1Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea. bhjeon@cnu.ac.kr
  • 2Department of Medical Science, Chungnam National University, Daejeon, Korea.
  • 3Department of Urology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.

Abstract

PURPOSE
Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein involved in DNA repair and redox modulation. Recently, serum and urinary APE1/Ref-1 levels were reported to be increased in patients with bladder cancer. Genetic variations of APE/Ref-1 are associated with the risk of cancer. However, the effect of APE1/Ref-1 variants on its secretory activity is yet unknown.
METHODS
APE1/Ref-1 variants were evaluated by DNA sequencing analysis of reverse transcription polymerase chain reaction products in coding DNA sequences (CDS) of APE1/Ref-1 in bladder tissue samples from patients with bladder cancer (n=10). Secretory activity of APE1/Ref-1 variants was evaluated with immunoblot and enzyme-linked immunosorbent assay of the culture medium supernatants.
RESULTS
Four different substitution mutants (D148E, I64V/D148E, W67R/D148E, and E86G/D148E) of APE1/Ref-1 were identified in bladder cancer specimens. However, deletion mutants of APE1/Ref-1 CDS were not found. The secretory activity of the APE1/Ref-1 variants (D148E, I64V/D148E, and E86G/D148E) was increased compared to that of wild type APE1/Ref-1. Furthermore, the secretory activity in basal or hyperacetylated conditions was much higher than that in APE1/Ref-1 D148E-transfected HEK293 cells.
CONCLUSIONS
Taken together, our data suggest that the increased secretory activity of D148E might contribute to increased serum levels of APE1/Ref-1 in patients with bladder cancer.

Keyword

Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (APE1/Ref-1); Point Mutation; Secretion; Enzyme-Linked Immunosorbent Assay; Bladder Cancer

MeSH Terms

Base Sequence
Clinical Coding
DNA Repair
Enzyme-Linked Immunosorbent Assay
Genetic Variation
HEK293 Cells
Humans*
Oxidation-Reduction
Point Mutation
Polymerase Chain Reaction
Reverse Transcription
Sequence Analysis, DNA
Urinary Bladder Neoplasms*
Urinary Bladder*
Full Text Links
  • INJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr